Novartis

Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is dedicated to innovative medicines aimed at improving and extending people's lives. Established in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is one of the largest pharmaceutical manufacturers globally, with a market capitalization of approximately $220 billion and projected revenue of $50.32 billion for 2024. The company focuses on five major therapeutic areas: cardiovascular, renal and metabolic diseases; neuroscience; oncology; immunology; and ophthalmology. Novartis offers a range of patent-protected prescription medicines for serious conditions, including key brands like Entresto, Cosentyx, and Kisqali. It also develops therapies utilizing RNA, gene therapy, cell therapy, and radioligands. With a workforce of around 74,000 to 108,000 employees across more than 140 nationalities, Novartis operates in over 40 countries and maintains more than 30 production facilities to ensure global access to its medicines.

Overview

Novartis lists 16 open roles based in New York, of 1873 worldwide. [1]

Open roles (40)

+ 20 more open roles →

visa sponsorship

  • Novartis has filed 2,009 H-1B labour condition applications between 2010 and 2026, across 4 filing entities.[2]

Something wrong or missing? Send an update. Fixed within 24 hours.